欧州の人工呼吸器市場の産業動向と2033年までの予測Europe Ventilator Market Industry Trends and Forecast to 2033 欧州の人工呼吸器市場は、2023年の19億2087万米ドルから2031年には34億6641万米ドルに達し、2024年から2031年の予測期間中に年平均成長率7.9%で成長すると予測されている。 市場セグメンテーション フランス... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー欧州の人工呼吸器市場は、2023年の19億2087万米ドルから2031年には34億6641万米ドルに達し、2024年から2031年の予測期間中に年平均成長率7.9%で成長すると予測されている。市場セグメンテーション フランス, スペイン, イタリア, スイス, オランダ, ベルギー, ロシア, トルコ, その他ヨーロッパ) - 産業動向と2031年までの予測 欧州の人工呼吸器市場ダイナミクスの概要 促進要因 - 慢性呼吸器疾患の有病率の増加 - 呼吸障害を起こしやすい老年人口の増加 抑制要因 - 人工呼吸器使用に伴う副作用 機会 - 医療費の増加 市場プレーヤー 欧州の人工呼吸器市場で事業を展開する主な市場プレーヤーは以下の通り: - Koninklijke Philips N.V. -GEヘルスケア -ヴァイエール -Drägerwerk AG & Co.KGaA -ゲッティンゲAB -メドトロニック -エア・リキード -シンセン・ミンドレイ・バイオメディカル・エレクトロニクス社 -スミス・グループ plc -レスメッド -ハミルトンメディカル -フィッシャー&ペイケル・ヘルスケア・リミテッド -ペンロン社 -ゾール・メディカル・コーポレーション 目次TABLE OF CONTENTS1 INTRODUCTION 20 1.1 OBJECTIVES OF THE STUDY 20 1.2 MARKET DEFINITION 20 1.3 OVERVIEW OF THE EUROPE VENTILATOR MARKET 20 1.4 LIMITATIONS 22 1.5 MARKETS COVERED 22 2 MARKET SEGMENTATION 24 2.1 MARKETS COVERED 24 2.2 GEOGRAPHICAL SCOPE 25 2.3 YEARS CONSIDERED FOR THE STUDY 26 2.4 CURRENCY AND PRICING 26 2.5 DBMR TRIPOD DATA VALIDATION MODEL 27 2.6 MULTIVARIATE MODELLING 30 2.7 PRODUCT TYPE VENTILATOR LIFELINE CURVE 31 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32 2.9 DBMR MARKET POSITION GRID 33 2.10 SECONDARY SOURCES 34 2.11 ASSUMPTIONS 34 3 EXECUTIVE SUMMARY 35 4 PREMIUM INSIGHTS 38 5 MARKET OVERVIEW 39 5.1 DRIVERS 41 5.1.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISEASES 41 5.1.2 INCREASING GERIATRIC POPULATION PRONE TO RESPIRATORY DISORDERS 42 5.1.3 INCREASING NUMBER OF ICU BED 42 5.1.4 TECHNOLOGICAL ADVANCEMENT IN THE VENTILATORS 43 5.2 RESTRAINTS 44 5.2.1 SIDE EFFECTS ASSOCIATED WITH THE USAGE OF VENTILATORS 44 5.2.2 HIGH COST OF VENTILATORS 45 5.3 OPPORTUNITIES 46 5.3.1 INCREASING HEALTHCARE EXPENDITURE 46 5.3.2 RISING NUMBER OF PREMATURE BIRTHS 48 5.3.3 INCREASING USAGE OF ICU EQUIPMENT 49 5.4 CHALLENGE 50 5.4.1 STRINGENT LEGAL FRAMEWORK 50 5.4.2 RISK ASSOCIATED WITH THE MECHANICAL VENTILATION 51 6 EUROPE VENTILATOR MARKET, BY PRODUCT TYPE 53 6.1 OVERVIEW 54 6.2 INTENSIVE CARE VENTILATORS 57 6.2.1 HIGH-END ICU VENTILATORS 58 6.2.2 BASIC ICU VENTILATORS 58 6.2.3 MID-END ICU VENTILATORS 58 6.3 PORTABLE VENTILATORS 58 6.4 NEONATAL VENTILATORS 58 7 EUROPE VENTILATOR MARKET, BY MODALITY 59 7.1 OVERVIEW 60 7.2 INVASIVE VENTILATION 63 7.3 NON-INVASIVE VENTILATION 63 7.3.1 VOLUME-CYCLED VENTILATORS 64 7.3.2 PRESSURE-CYCLED VENTILATORS 64 7.3.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS 64 7.3.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS 64 7.3.5 FLOW-CYCLED VENTILATORS 64 7.3.6 TIME-CYCLED VENTILATORS 64 8 EUROPE VENTILATOR MARKET, BY VENTILATOR TYPE 65 8.1 OVERVIEW 66 8.2 ADULT VENTILATORS 69 8.3 NEONATAL VENTILATORS 69 8.4 PEDIATRIC VENTILATORS 70 9 EUROPE VENTILATOR MARKET, BY MODE 71 9.1 OVERVIEW 72 9.2 COMBINED-MODE VENTILATION 75 9.3 VOLUME-MODE VENTILATION 75 9.4 PRESSURE-MODE VENTILATOR 76 9.5 OTHER 76 10 EUROPE VENTILATOR MARKET, BY END USER 77 10.1 OVERVIEW 78 10.2 HOSPITALS 81 10.3 SPECIALTY CLINICS 81 10.4 HOMECARE SETTINGS 82 10.5 LONG TERM CARE CENTRES 82 10.6 REHABILITATION CENTRES 83 10.7 OTHERS 83 11 EUROPE VENTILATOR MARKET, BY REGION 84 11.1 EUROPE 86 11.1.1 U.K. 91 11.1.2 FRANCE 94 11.1.3 SPAIN 97 11.1.4 ITALY 100 11.1.5 SWITZERLAND 103 11.1.6 NETHERLANDS 106 11.1.7 BELGIUM 109 11.1.8 RUSSIA 112 11.1.9 TURKEY 115 11.1.10 REST OF EUROPE 118 12 EUROPE VENTILATOR MARKET: COMPANY LANDSCAPE 119 12.1 COMPANY SHARE ANALYSIS: EUROPE 119 13 SWOT ANALYSIS 120 14 COMPANY PROFILES 121 14.1 KONINKLIJKE PHILIPS N.V. 121 14.1.1 COMPANY SNAPSHOT 121 14.1.2 REVENUE ANALYSIS 121 14.1.3 COMPANY SHARE ANALYSIS 122 14.1.4 PRODUCT PORTFOLIO 122 14.1.5 RECENT DEVELOPMENT 124 14.2 GE HEALTHCARE 125 14.2.1 COMPANY SNAPSHOT 125 14.2.2 REVENUE ANALYSIS 125 14.2.3 COMPANY SHARE ANALYSIS 126 14.2.4 PRODUCT PORTFOLIO 126 14.2.5 RECENT DEVELOPMENT 126 14.3 VYAIRE 127 14.3.1 COMPANY SNAPSHOT 127 14.3.2 COMPANY SHARE ANALYSIS 127 14.3.3 PRODUCT PORTFOLIO 128 14.3.4 RECENT DEVELOPMENTS 131 14.4 DRÄGERWERK AG & CO. KGAA 132 14.4.1 COMPANY SNAPSHOT 132 14.4.2 REVENUE ANALYSIS 132 14.4.3 COMPANY SHARE ANALYSIS 133 14.4.4 PRODUCT PORTFOLIO 133 14.4.5 RECENT DEVELOPMENTS 136 14.5 GETINGE AB 137 14.5.1 COMPANY SNAPSHOT 137 14.5.2 REVENUE ANALYSIS 137 14.5.3 COMPANY SHARE ANALYSIS 138 14.5.4 PRODUCT PORTFOLIO 138 14.5.5 RECENT DEVELOPMENT 139 14.6 AIR LIQUIDE 140 14.6.1 COMPANY SNAPSHOT 140 14.6.2 REVENUE ANALYSIS 140 14.6.3 PRODUCT PORTFOLIO 141 14.6.4 RECENT DEVELOPMENT 142 14.7 FISHER & PAYKEL HEALTHCARE LIMITED 143 14.7.1 COMPANY SNAPSHOT 143 14.7.2 REVENUE ANALYSIS 143 14.7.3 PRODUCT PORTFOLIO 144 14.7.4 RECENT DEVELOPMENTS 144 14.8 HAMILTON MEDICAL 145 14.8.1 COMPANY SNAPSHOT 145 14.8.2 PRODUCT PORTFOLIO 145 14.8.3 RECENT DEVELOPMENTS 147 14.9 LEISTUNG EQUIPAMENTOS LTDA. 148 14.9.1 COMPANY SNAPSHOT 148 14.9.2 PRODUCT PORTFOLIO 148 14.9.3 RECENT DEVELOPMENT 148 14.10 MEDTRONIC 149 14.10.1 COMPANY SNAPSHOT 149 14.10.2 REVENUE ANALYSIS 149 14.10.3 PRODUCT PORTFOLIO 150 14.10.4 RECENT DEVELOPMENTS 151 14.11 PENLON LIMITED 152 14.11.1 COMPANY SNAPSHOT 152 14.11.2 PRODUCT PORTFOLIO 152 14.11.3 RECENT DEVELOPMENT 153 14.12 RESMED 154 14.12.1 COMPANY SNAPSHOT 154 14.12.2 REVENUE ANALYSIS 154 14.12.3 PRODUCT PORTFOLIO 155 14.12.4 RECENT DEVELOPMENTS 156 14.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 157 14.13.1 COMPANY SNAPSHOT 157 14.13.2 PRODUCT PORTFOLIO 157 14.13.3 RECENT DEVELOPMENT 159 14.14 SMITHS GROUP PLC 160 14.14.1 COMPANY SNAPSHOT 160 14.14.2 REVENUE ANALYSIS 160 14.14.3 PRODUCT PORTFOLIO 161 14.14.4 RECENT DEVELOPMENT 162 14.15 ZOLL MEDICAL CORPORATION 163 14.15.1 COMPANY SNAPSHOT 163 14.15.2 PRODUCT PORTFOLIO 163 14.15.3 RECENT DEVELOPMENT 164 15 QUESTIONNAIRE 165 16 RELATED REPORTS 168
SummaryThe Europe ventilator market is expected to reach USD 3,466.41 million by 2031 from USD 1,902.87 million in 2023, growing at a CAGR of 7.9% during the forecast period of 2024 to 2031. Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 20 1.1 OBJECTIVES OF THE STUDY 20 1.2 MARKET DEFINITION 20 1.3 OVERVIEW OF THE EUROPE VENTILATOR MARKET 20 1.4 LIMITATIONS 22 1.5 MARKETS COVERED 22 2 MARKET SEGMENTATION 24 2.1 MARKETS COVERED 24 2.2 GEOGRAPHICAL SCOPE 25 2.3 YEARS CONSIDERED FOR THE STUDY 26 2.4 CURRENCY AND PRICING 26 2.5 DBMR TRIPOD DATA VALIDATION MODEL 27 2.6 MULTIVARIATE MODELLING 30 2.7 PRODUCT TYPE VENTILATOR LIFELINE CURVE 31 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32 2.9 DBMR MARKET POSITION GRID 33 2.10 SECONDARY SOURCES 34 2.11 ASSUMPTIONS 34 3 EXECUTIVE SUMMARY 35 4 PREMIUM INSIGHTS 38 5 MARKET OVERVIEW 39 5.1 DRIVERS 41 5.1.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISEASES 41 5.1.2 INCREASING GERIATRIC POPULATION PRONE TO RESPIRATORY DISORDERS 42 5.1.3 INCREASING NUMBER OF ICU BED 42 5.1.4 TECHNOLOGICAL ADVANCEMENT IN THE VENTILATORS 43 5.2 RESTRAINTS 44 5.2.1 SIDE EFFECTS ASSOCIATED WITH THE USAGE OF VENTILATORS 44 5.2.2 HIGH COST OF VENTILATORS 45 5.3 OPPORTUNITIES 46 5.3.1 INCREASING HEALTHCARE EXPENDITURE 46 5.3.2 RISING NUMBER OF PREMATURE BIRTHS 48 5.3.3 INCREASING USAGE OF ICU EQUIPMENT 49 5.4 CHALLENGE 50 5.4.1 STRINGENT LEGAL FRAMEWORK 50 5.4.2 RISK ASSOCIATED WITH THE MECHANICAL VENTILATION 51 6 EUROPE VENTILATOR MARKET, BY PRODUCT TYPE 53 6.1 OVERVIEW 54 6.2 INTENSIVE CARE VENTILATORS 57 6.2.1 HIGH-END ICU VENTILATORS 58 6.2.2 BASIC ICU VENTILATORS 58 6.2.3 MID-END ICU VENTILATORS 58 6.3 PORTABLE VENTILATORS 58 6.4 NEONATAL VENTILATORS 58 7 EUROPE VENTILATOR MARKET, BY MODALITY 59 7.1 OVERVIEW 60 7.2 INVASIVE VENTILATION 63 7.3 NON-INVASIVE VENTILATION 63 7.3.1 VOLUME-CYCLED VENTILATORS 64 7.3.2 PRESSURE-CYCLED VENTILATORS 64 7.3.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS 64 7.3.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS 64 7.3.5 FLOW-CYCLED VENTILATORS 64 7.3.6 TIME-CYCLED VENTILATORS 64 8 EUROPE VENTILATOR MARKET, BY VENTILATOR TYPE 65 8.1 OVERVIEW 66 8.2 ADULT VENTILATORS 69 8.3 NEONATAL VENTILATORS 69 8.4 PEDIATRIC VENTILATORS 70 9 EUROPE VENTILATOR MARKET, BY MODE 71 9.1 OVERVIEW 72 9.2 COMBINED-MODE VENTILATION 75 9.3 VOLUME-MODE VENTILATION 75 9.4 PRESSURE-MODE VENTILATOR 76 9.5 OTHER 76 10 EUROPE VENTILATOR MARKET, BY END USER 77 10.1 OVERVIEW 78 10.2 HOSPITALS 81 10.3 SPECIALTY CLINICS 81 10.4 HOMECARE SETTINGS 82 10.5 LONG TERM CARE CENTRES 82 10.6 REHABILITATION CENTRES 83 10.7 OTHERS 83 11 EUROPE VENTILATOR MARKET, BY REGION 84 11.1 EUROPE 86 11.1.1 U.K. 91 11.1.2 FRANCE 94 11.1.3 SPAIN 97 11.1.4 ITALY 100 11.1.5 SWITZERLAND 103 11.1.6 NETHERLANDS 106 11.1.7 BELGIUM 109 11.1.8 RUSSIA 112 11.1.9 TURKEY 115 11.1.10 REST OF EUROPE 118 12 EUROPE VENTILATOR MARKET: COMPANY LANDSCAPE 119 12.1 COMPANY SHARE ANALYSIS: EUROPE 119 13 SWOT ANALYSIS 120 14 COMPANY PROFILES 121 14.1 KONINKLIJKE PHILIPS N.V. 121 14.1.1 COMPANY SNAPSHOT 121 14.1.2 REVENUE ANALYSIS 121 14.1.3 COMPANY SHARE ANALYSIS 122 14.1.4 PRODUCT PORTFOLIO 122 14.1.5 RECENT DEVELOPMENT 124 14.2 GE HEALTHCARE 125 14.2.1 COMPANY SNAPSHOT 125 14.2.2 REVENUE ANALYSIS 125 14.2.3 COMPANY SHARE ANALYSIS 126 14.2.4 PRODUCT PORTFOLIO 126 14.2.5 RECENT DEVELOPMENT 126 14.3 VYAIRE 127 14.3.1 COMPANY SNAPSHOT 127 14.3.2 COMPANY SHARE ANALYSIS 127 14.3.3 PRODUCT PORTFOLIO 128 14.3.4 RECENT DEVELOPMENTS 131 14.4 DRÄGERWERK AG & CO. KGAA 132 14.4.1 COMPANY SNAPSHOT 132 14.4.2 REVENUE ANALYSIS 132 14.4.3 COMPANY SHARE ANALYSIS 133 14.4.4 PRODUCT PORTFOLIO 133 14.4.5 RECENT DEVELOPMENTS 136 14.5 GETINGE AB 137 14.5.1 COMPANY SNAPSHOT 137 14.5.2 REVENUE ANALYSIS 137 14.5.3 COMPANY SHARE ANALYSIS 138 14.5.4 PRODUCT PORTFOLIO 138 14.5.5 RECENT DEVELOPMENT 139 14.6 AIR LIQUIDE 140 14.6.1 COMPANY SNAPSHOT 140 14.6.2 REVENUE ANALYSIS 140 14.6.3 PRODUCT PORTFOLIO 141 14.6.4 RECENT DEVELOPMENT 142 14.7 FISHER & PAYKEL HEALTHCARE LIMITED 143 14.7.1 COMPANY SNAPSHOT 143 14.7.2 REVENUE ANALYSIS 143 14.7.3 PRODUCT PORTFOLIO 144 14.7.4 RECENT DEVELOPMENTS 144 14.8 HAMILTON MEDICAL 145 14.8.1 COMPANY SNAPSHOT 145 14.8.2 PRODUCT PORTFOLIO 145 14.8.3 RECENT DEVELOPMENTS 147 14.9 LEISTUNG EQUIPAMENTOS LTDA. 148 14.9.1 COMPANY SNAPSHOT 148 14.9.2 PRODUCT PORTFOLIO 148 14.9.3 RECENT DEVELOPMENT 148 14.10 MEDTRONIC 149 14.10.1 COMPANY SNAPSHOT 149 14.10.2 REVENUE ANALYSIS 149 14.10.3 PRODUCT PORTFOLIO 150 14.10.4 RECENT DEVELOPMENTS 151 14.11 PENLON LIMITED 152 14.11.1 COMPANY SNAPSHOT 152 14.11.2 PRODUCT PORTFOLIO 152 14.11.3 RECENT DEVELOPMENT 153 14.12 RESMED 154 14.12.1 COMPANY SNAPSHOT 154 14.12.2 REVENUE ANALYSIS 154 14.12.3 PRODUCT PORTFOLIO 155 14.12.4 RECENT DEVELOPMENTS 156 14.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 157 14.13.1 COMPANY SNAPSHOT 157 14.13.2 PRODUCT PORTFOLIO 157 14.13.3 RECENT DEVELOPMENT 159 14.14 SMITHS GROUP PLC 160 14.14.1 COMPANY SNAPSHOT 160 14.14.2 REVENUE ANALYSIS 160 14.14.3 PRODUCT PORTFOLIO 161 14.14.4 RECENT DEVELOPMENT 162 14.15 ZOLL MEDICAL CORPORATION 163 14.15.1 COMPANY SNAPSHOT 163 14.15.2 PRODUCT PORTFOLIO 163 14.15.3 RECENT DEVELOPMENT 164 15 QUESTIONNAIRE 165 16 RELATED REPORTS 168
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Data Bridge Market Research社の医療デバイス分野での最新刊レポート
本レポートと同じKEY WORD(ventilator)の最新刊レポートよくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|